FRI0253 Use of bosentan for the prevention of digital ulcers related to systemic sclerosis. Retrospective french study of 89 patients treated since 2007
C. Agard(Centre National de la Recherche Scientifique), É. Hachulla(Centre Hospitalier Universitaire de Lille), Virginie Gressin, A. Bérezné(Université Paris Cité), I. Quéré(Centre Hospitalier Universitaire de Montpellier), Emmanuel Chatelus(Laboratoire National de Référence), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), P. Carpentier(Centre Hospitalier Universitaire de Grenoble), Pierre Clerson, A. Khau Van Kien(Hôpital Saint Eloi), Luc Mouthon(Université Paris Cité)
Cited by 0
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699